[DNLI] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 0.90%
YoY- -25.87%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 22,939 7,923 316,815 9,393 5,847 3,604 4,672 189.15%
PBT -60,691 -70,041 245,708 -58,172 -58,679 -56,898 -53,950 8.17%
Tax 728 -2,108 823 56 79 -135 75 355.66%
NP -60,691 -70,041 244,885 -58,228 -58,758 -56,763 -54,025 8.07%
Tax Rate - - -0.33% - - - - -
Total Cost 83,630 77,964 71,930 67,621 64,605 60,367 58,697 26.64%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -264.58 -884.02 77.30 -619.91 -1,004.93 -1,575.00 -1,156.36 -62.62%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.50 -0.58 2.04 -0.54 -0.56 -0.55 -0.57 -8.37%
EPS Diluted -0.49 -0.58 1.91 -0.54 -0.56 -0.55 -0.56 -8.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.